Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Head & Neck 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1

Conditions

Pancreatic Neoplasms 2Hypoxia 2Rectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × pimonidazole × Gastrointestinal × Clear all
NCT03718650 2021-02-08

Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT01248637 2018-07-30

Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole

University Health Network, Toronto

Completed
200 enrolled
Gastrointestinal

Hypoxia, Pancreatic Neoplasms

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed
14 enrolled
Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡